Global Crigler-Najjar Syndrome Drug Market Insights 2019-2026

The Global Crigler–Najjar syndrome market is expected to witness market growth at a rate of 5% in the forecast period of 2021 to 2028.
Crigler–Najjar syndrome refers to rare genetic liver disorder characterized by abnormal accumulation of bilirubin that is a yellow pigment produced by the liver. This accumulation is occurred by deficiency of the enzyme called UGT1A1. This enzyme converts bilirubin into a substance that can be eliminated.
Get Full Access of Report @ https://www.databridgemarketresearch.com/reports/global-criglernajjar-syndrome-market